BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 25772989)

  • 21. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses.
    Gooskens J; Jonges M; Claas EC; Meijer A; Kroes AC
    J Infect Dis; 2009 May; 199(10):1435-41. PubMed ID: 19392620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral and cytotoxic activity of netropsin derivatives in vero cells infected with vaccinia virus and herpes simplex virus type I.
    Andronova VL; Grokhovsky SL; Surovaya AN; Arkhipova VS; Gursky GV; Galegov GA
    Dokl Biochem Biophys; 2008; 422():296-301. PubMed ID: 19024561
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
    Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
    Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antiviral activity of the combinations of netropsin derivatives with modified nucleosides and phosphonoacetic acid as estimated in the model of herpesvirus type 1 in a vero cell culture.
    Andronova VL; Grokhovsky SL; Surovaya AN; Gursky GV; Galegov GA
    Dokl Biochem Biophys; 2005; 400():84-7. PubMed ID: 15846992
    [No Abstract]   [Full Text] [Related]  

  • 25. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.
    Danve-Szatanek C; Aymard M; Thouvenot D; Morfin F; Agius G; Bertin I; Billaudel S; Chanzy B; Coste-Burel M; Finkielsztejn L; Fleury H; Hadou T; Henquell C; Lafeuille H; Lafon ME; Le Faou A; Legrand MC; Maille L; Mengelle C; Morand P; Morinet F; Nicand E; Omar S; Picard B; Pozzetto B; Puel J; Raoult D; Scieux C; Segondy M; Seigneurin JM; Teyssou R; Zandotti C
    J Clin Microbiol; 2004 Jan; 42(1):242-9. PubMed ID: 14715760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation.
    Langston AA; Redei I; Caliendo AM; Somani J; Hutcherson D; Lonial S; Bucur S; Cherry J; Allen A; Waller EK
    Blood; 2002 Feb; 99(3):1085-8. PubMed ID: 11807018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Difference in incidence of spontaneous mutations between Herpes simplex virus types 1 and 2.
    Sarisky RT; Nguyen TT; Duffy KE; Wittrock RJ; Leary JJ
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1524-9. PubMed ID: 10817703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.
    Kimberlin DF; Weller S; Whitley RJ; Andrews WW; Hauth JC; Lakeman F; Miller G
    Am J Obstet Gynecol; 1998 Oct; 179(4):846-51. PubMed ID: 9790357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
    Ayisi NK; Gupta SV; Babiuk LA
    Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of nucleoside-resistant variants of HIV-1 by in vitro selection in the presence of AZT or DDI but no by combinations.
    Gao Q; Parniak MA; Gu Z; Wainberg MA
    Leukemia; 1992; 6 Suppl 3():192S-195S. PubMed ID: 1602823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dimeric netropsin analogue 15Lys-bis-Nt and acyclovir on the reproduction of herpes simplex virus type 1. The search for variants of herpes virus with drug resistance to 15Lys-bis-Nt and acyclovir.
    Andronova VL; Grokhovsky SL; Surovaya AN; Gursky GV; Galegov GA
    Dokl Biochem Biophys; 2015; 460():42-6. PubMed ID: 25772989
    [No Abstract]   [Full Text] [Related]  

  • 32. Lexitropsins in antiviral drug development.
    Lown JW
    Antiviral Res; 1992 Mar; 17(3):179-96. PubMed ID: 1314535
    [No Abstract]   [Full Text] [Related]  

  • 33. Acyclovir: mechanism of antiviral action and potentiation by ribonucleotide reductase inhibitors.
    Reardon JE; Spector T
    Adv Pharmacol; 1991; 22():1-27. PubMed ID: 1958500
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.